“We are very excited about this agreement as it will launch us into the worldwide bovine tuberculosis testing market. This affliction costs the worldwide cattle industry billions of dollars per year in losses and is a major health concern for both cattle and humans,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “The handheld unit we plan to offer Bright Dairy for distribution throughout China is the same technology platform developed by a U.S. National Laboratory that we will use to enter the market for malaria testing.” Our eventual goal is to be the worldwide leader in handheld diagnostic systems for both of the bovine TB and malaria testing markets. This agreement moves us significantly toward this goal.
